Immunocytochemistry was used to localize endothelial (eNOS) and inducible (iNOS) nitric oxide synthase in human uterine tissues collected at various stages of the menstrual cycle, after exposure to exogenous progestagens, and in early pregnancy. Endothelial NOS-like immunoreactivity was detected in all specimens in endothelial cells lining blood vessels in the myometrium and endometrium, and in endometrial glandular epithelial cells. Inducible NOS-like immunoreactivity was also demonstrated in glandular epithelial cells. For both eNOS and iNOS there was considerable variation in the intensity of epithelial cell staining between samples, which was not related to the stage of the menstrual cycle at which the tissue was collected. Messenger RNA for eNOS and iNOS was detected by reverse transcription-polymerase chain reaction (RT-PCR) using total RNA purified from isolated endometrial gland fragments. Immunoreactivity for eNOS and iNOS was not present in endometrial stroma throughout the menstrual cycle, but iNOS-like immunoreactivity was seen in decidualized stromal cells both following treatment with exogenous progestagen (intrauterine L-norgestrel) and in tissues obtained in the first trimester of pregnancy. The detection of protein and mRNA for eNOS and iNOS in normal human endometrium suggests that NO may play a role in the local control of endometrial function.
Introduction
epithelium (Schmidt et al., 1992) . We have previously described the presence of eNOS protein and mRNA, and Nitric oxide (NO) is a crucial mediator of paracrine interactions, NADPH diaphorase activity, in human endometrium (Telfer especially within the vascular system. It is a powerful inhibitor et al., 1995) . In addition, recent work has shown that human of platelet aggregation and a potent vasodilator (Palmer et al., endometrial glandular cells expressed eNOS mRNA throughout 1987). Nitric oxide also functions as a neurotransmitter and the menstrual cycle, whilst the expression of iNOS mRNA plays a role in cell-mediated cytotoxicity (Lowenstein and was confined to epithelial glands isolated from menstrual Snyder, 1992) . This signalling molecule is therefore likely to endometrium (Tseng et al., 1996) . have an important role within the endometrium where changes
The onset of menstruation is characterized by intense vasoin vascular function occur throughout the course of the constriction (Markee, 1940) . Most of the functional endomenstrual cycle and at the time of implantation. Although it metrium is shed within 20 h of the onset of bleeding, and is difficult to determine which cells produce NO in vivo, subsequent haemostasis is thought to be achieved not by the circumstantial evidence of its production by particular cell deposition of platelet-fibrin plugs, but by vasoconstriction types can be obtained by localizing the enzymes which (Christiaens et al., 1980) . Nitric oxide produced in the human synthesize it.
endometrium may play a role in the control of menstruation NO is produced by nitric oxide synthases (NOSs), a family (and implantation) by virtue of its roles as a vasodilator and of isoenzymes that catalyse the oxidation of L-arginine to nitric an inhibitor of platelet aggregation. Animal studies have oxide (NO) and citrulline. There are two functional classes of suggested that NO, acting via second messenger cGMP, may NOS, based on the requirement of these enzymes for calcium contribute to the maintenance of uterine quiescence during (Moncada et al., 1991) . Inducible NOS (iNOS or type II), pregnancy (Natuzzi et al., 1993; Sladek et al., 1993) . Thus which is calcium-independent, binds calmodulin tightly at NO produced in the endometrium may also have an effect on resting intracellular calcium concentrations. Endothe underlying myometrium. thelial NOS (eNOS or type III), originally described in
The aim of the present study was to determine the localization endothelial cells, and neuronal NOS (nNOS or type I) are both of eNOS and iNOS protein in human endometrium by immunodependent on calcium for activity.
cytochemistry, and to detect the presence of mRNA for eNOS The production of NO in the endometrium has not been and iNOS using the reverse transcription-polymerase chain widely addressed, but iNOS protein has been reported in reaction (RT-PCR) on enriched preparations of glandular endometrial epithelial cells in the mouse (Huang et al., 1995) and neuronal NOS protein has been detected in rat endometrial epithelium. The effect of ovarian steroids on the expression Localization of eNOS and iNOS in decidualized stroma was alcohol series. The sections were pre-incubated with 3% (w/v) also studied in tissues from women with normal pregnancies immunoglobulin-free bovine serum albumin (BSA; Sigma) in PBS undergoing induced abortion in the first trimester.
(10 mM sodium phosphate, pH 7.5, 120 mM sodium chloride) for 20 min at room temperature. They were then incubated for 1 h at room temperature with a monoclonal antibody against human eNOS (Affiniti, Nottingham, UK), diluted 1/500 in 3% BSA. Sections were
Materials and methods
then washed in 0.1% Triton-X100, followed by two washes in PBS. Immunocytochemistry for iNOS women subsequently received oral norethisterone (5 mg three times Immunocytochemistry was performed on paraffin-embedded sections daily from days 5 to 26 of the cycle) and six received L-norgestrel, using a polyclonal antibody raised against amino acids 1131-1144 as the L-norgestrel intrauterine system (LNG-IUS, Mirena ® ; Leiras of murine iNOS (Cambridge Biosciences, Cambridge, UK) diluted Oy, Turku, Finland). The LNG-IUS, which releases 20 µg LNG daily, 1/400 in PBS. Antibody binding was detected using an anti-rabbit was inserted within 5 days of the onset of menstruation. Endometrial immunoglobulin (Ig)G peroxidase kit (Vectastain Elite ABC Kit; biopsies were taken using a Z-Sampler endometrial suction curette Vector) and DAB substrate (Sigma), according to the manufacturer's (Zinnanti, Chatsworth, CA, USA) at a median of 21 days (range instructions. Control slides were incubated without primary antibody. 19-25) after the onset of menstruation during a pre-treatment control Human DLD-1 colorectal adenocarcinoma cells (European Collection cycle. A second post-treatment biopsy was taken after a median of of Animal Cell Cultures, Porton Down, UK), which have previously 18 days (range 13-24) exposure to L-norgestrel and 17 days (range been shown to express iNOS (Sherman et al., 1993) , were cultured 13-20) exposure to norethisterone.
Collection of tissue from women with normal menstrual
in RPMI 1640 (Life Technologies) supplemented with 10% heat inactivated fetal calf serum, 100 µg/ml interferon (Sigma), 10 ng/ml Collection of first trimester decidua tumour necrosis factor (Sigma) and 0.5 ng/ml interleukin-1 (Sigma) Decidual tissue was collected from 10 women with normal pregnancies for 24 h, and used as a positive control. undergoing surgical termination in the first trimester.
Immunocytochemistry was also performed on frozen sections with a polyclonal anti-human iNOS antibody raised against amino acids Isolation of endometrial gland fragments 1135 -1153 . The antibody was Biopsies of endometrium were transported to the laboratory in cold diluted 1/200 in PBS and immunocytochemistry was carried out using Roswell Park Memorial Institute (RPMI) 1640 medium containing an anti-rabbit IgG peroxidase kit (Vectastain Elite ABC Kit; Vector) 100 IU/ml penicillin and 100 µg/ml streptomycin (Life Technologies, according to the manufacturer's instructions. Paisley, UK). The tissue was washed three times in RPMI medium Detection of endothelial cells using Ulex europaeus and chopped into small pieces using a sterile scalpel. Tissue pieces agglutinin 1 (UEA 1) lectin were placed in a sterile tube with 1 mg/ml collagenase (Type I; Sigma, Poole, Dorset, UK) in RPMI medium, supplemented with Lectin binding was carried out on 10 µm frozen sections of endometpenicillin and streptomycin, and incubated at 37°C for 2-4 h. rium and myometrium mounted on silane-coated slides. The sections Undigested tissue was removed using a sterile 400 µm woven were fixed in acetone at room temperature for 20 min, air-dried and polyester mesh (Lockertex; Locker Wire Weavers Ltd., Warrington, rehydrated in 10 mM HEPES, pH 7.5, 0.15 M NaCl, then placed in UK) and the filtrate was collected. This filtrate was passed through 0.3% H 2 O 2 in methanol for 30 min to remove endogenous peroxidase a 30 µm mesh and trapped epithelial gland fragments were backactivity. Biotinylated Ulex europaeus agglutinin 1 (UEA 1) lectin washed using sterile Dulbecco's phosphate-buffered saline (D-PBS, (5 µg/ml, Vector) was applied to the section in HEPES, NaCl buffer for 1 h at room temperature. Avidin-biotin-peroxidase complex Life Technologies).
(Vectastain Elite ABC Kit; Vector) and DAB substrate were then analysed on an automated 373A DNA sequencer (Applied Biosystems, Warrington, UK) used to detect lectin binding.
Identification of decidual stromal cells in first trimester

Results decidua
Cryostat sections were fixed in acetone at 4°C for 10 min, air-dried eNOS and iNOS immunocytochemistry across the and rinsed in PBS for 10 min. Decidual cells were identified with a normal menstrual cycle polyclonal antibody against vimentin (Euro-Path Ltd, Bude, UK).
Immunocytochemistry for eNOS and iNOS was carried out
Glands and trophoblast were localized using a monoclonal antibody on paraffin sections from 21 women. Six were in the proliferaagainst cytokeratins (clone MNF 116, Dako, High Wycombe, UK).
tive phase of the cycle, 11 were in the secretory phase [early The sections were pre-incubated for 20 min in D-PBS supplemented secretory (days 14-18) n ϭ 6, mid-secretory (days 19-24) with 1.5% BSA. The primary antibodies were applied for 60 min n ϭ 3, late secretory (days 25-28) n ϭ 2] and 4 were in the Immunolocalization of eNOS on cryosections from 11 heating to 80°C for 10 min. cDNA products were stored at Ϫ20°C until amplification. specimens confirmed eNOS was present in vascular endoPolymerase chain reaction (PCR) was undertaken with primers thelium and glandular epithelium. Although the pattern of (Oswell DNA Service, Southampton, UK) for human eNOS which localization was similar to that obtained on wax sections, the spanned exons 8-11 (Marsden et al., 1993) ; 5Ј-CAG TGT CCA ACA staining on cryosections was less extensive within the cyto-TGC TGC TGG AAA TTG-3Ј (1004-1030) and 5Ј-TAA AGG TCT plasm of individual epithelial cells.
TCT TCC TGG TGA TGC C-3Ј (1490 ( -1464 ( , Weiner et al., 1994 .
Amongst the nine women in whom menstrual blood loss Amplification of iNOS was carried out with primers (P.Romanowski, was measured before hysterectomy, five had a normal monthly L. Wallman, and D.J. Williamson, St Vincent's Hospital, Darlinghurst, blood loss (median 35 ml, range 28-76 ml) and four had Australia; personal communication) which spanned exon-intron menorrhagia (median 202 ml, range 98-265 ml). The intensity boundaries (Chartrain et al., 1994) ; 5Ј-GGA ATT CAC TCA GCT of immunostaining for eNOS in these samples did not appear GTG CAT CG-3Ј (1077-1099) and 5Ј-GTT TCC AGG CCC ATT to be related to the degree of menstrual blood loss.
CTC CTG C-3Ј (1433-1412). Amplifications were carried out using a programmable thermal cycler (TLA-2 Hybaid, Teddington, UK) in Inducible NOS-like immunoreactivity was investigated in a total volume of 50 µl containing 60 mM Tris-HCl, pH 8.5, 15 mM paraffin sections using the murine polyclonal antibody. Immunostaining was not present in endothelial cells, but was polymerase. A HotWax Mg 2ϩ bead (Invitrogen, Abingdon, UK) was detected in glandular epithelial cells ( Figure 1D ). Once more added to each tube. Amplifications were carried out with an initial there was a considerable difference in the intensity of staining denaturation step at 94°C for 2 min, followed by 30 cycles of 1 min between samples which was not related to the stage of the at 94°C, 1 min at 55°C and 1 min at 72°C. The final cycle menstrual cycle. As with the eNOS immunocytochemistry, a was followed by strand extension at 72°C for 10 min. Amplified gradation in staining was also observed between basal and products were analysed by electrophoresis using 1.5% agarose gels functional layers of the endometrium in four biopsies, two of and visualized by ethidium bromide staining.
which were obtained in the proliferative phase and two in
The PCR products were sequenced with an ABI PRISM dye the early to mid-secretory phase of the menstrual cycle.
terminator cycle sequencing kit (Perkin Elmer, Warrington) using AmpliTaq DNA polymerase, FS and the sequencing products were
Immunostaining of vascular smooth muscle in the myometrium, and of the myometrium itself, was seen in tissues from nine distinguishable from that observed in the biopsies from the 21 who underwent hysterectomy for benign disease. Endothelial women ( Figure 1E ). Control cultures of human DLD-1 cells treated with cytokines stained intensely with the anti-murine NOS-like immunoreactivity was confined to vascular endothelium and glandular epithelium, whilst iNOS-like immunoiNOS antibody ( Figure 1F ).
The pattern of immunolocalization obtained with the antireactivity was seen in glandular epithelium and in some vascular smooth muscle cells. Though immunoreactivity was human iNOS antibody on cryosections was identical to that obtained with the anti-murine iNOS antibody on paraffin present in all sections, there was marked variability in the intensity of staining for both vascular and epithelial cells. NOSsections.
like immunoreactivity was not detected in endometrial stroma.
Immunocytochemistry for eNOS and iNOS after treat-
Administration of norethisterone resulted in the appearance ment with exogenous progestagens of small areas of decidualization in tissues from two of the six patients, whereas a pronounced decidual reaction was seen The pattern of localization of eNOS and iNOS protein in the pre-treatment biopsies of 12 menorrhagic women was not in all endometrial specimens taken from the six women receiving LNG-IUS. Treatment with progestagen abolished metrium. Besides localization to the vascular compartment (eNOS to vascular endothelium and iNOS to vascular smooth eNOS immunoreactivity in glandular epithelial cells in all of muscle in some sections), eNOS-and iNOS-like immunoreacthe patients treated with the LNG-IUS and in three of those tivity and mRNA were detected in endometrial glandular treated with norethisterone ( Figure 2A) . Similarly, treatment epithelium. Whilst the intensity of immunostaining varied with the LNG-IUS caused an attenuation or loss of iNOS markedly between individuals, there was no clear relationship immunoreactivity within glandular epithelium. By contrast, with either the stage of the menstrual cycle at which tissues weak iNOS immunoreactivity appeared in the decidualized were obtained, or objectively-measured menstrual blood loss. stromal cells after exposure to LNG-IUS ( Figure 2B) .
Endothelial NOS or iNOS mRNA or protein were not found in NOS immunoreactivity in stromal cell of first endometrial stroma, but iNOS immunoreactivity was present in trimester decidua decidualized stroma in specimens obtained after the administration of synthetic progestagen and in the first trimester of Endothelial NOS-like immunoreactivity was localized to endopregnancy. thelial cells in five out of five biopsies of decidual tissue in In our previous work which assessed immunoreactivity in which eNOS localization was carried out. Localization of six women using a different monoclonal antibody raised in iNOS was examined on 10 decidual biopsies using both the mice against bovine eNOS, staining was detected in endomurine and human iNOS antibodies. With both antibodies, metrial stroma and myometrial blood vessels, with weak weak immunoreactivity was observed in decidual stromal cells staining in glandular epithelium in secretory endometrium ( Figure 2C ) which expressed vimentin but not cytokeratin, and (Telfer et al., 1995) . The present study with an anti-human in vascular smooth muscle.
eNOS monoclonal antibody revealed a consistent pattern of Reverse transcription-polymerase chain reaction eNOS-like immunoreactivity in vascular endothelium and glandular epithelium. Localization of eNOS protein to Messenger RNA for both eNOS and iNOS was detected glandular epithelium is supported by the distribution of by RT-PCR in total RNA extracted from enriched gland NADPH diaphorase activity (Telfer et al., 1995) , the detection preparations from proliferative and secretory phase endometria of mRNA for eNOS in glandular epithelium by Northern (Figure 3) . Sequencing of the amplified products revealed 95 analysis (Tseng et al., 1996) and RT-PCR as described here. and 99% homology with the published sequences of eNOS Demonstration of iNOS-like immunoreactivity in endoand iNOS respectively. RT-PCR for iNOS in control cultures metrial glandular epithelium was also supported by the detecof DLD-1 cells produced one intense band of the expected tion of iNOS mRNA in glandular epithelial cells by RT-RCR. size and equivalent to that observed in isolated gland fragments.
In addition, Tseng et al. (1996) detected mRNA for iNOS in enriched endometrial gland preparations by Northern blot Discussion analysis. However, in contrast to eNOS, iNOS message was This study has demonstrated the presence of mRNA and only found in glandular epithelia derived from menstrual endometrium; the different results obtained with RT-PCR and protein for both eNOS and iNOS in normal human endo- Figure 3 . Reverse transcription-polymerase chain reaction (RT-PCR) for (A) endothelial nitric oxide synthase (eNOS) and (B) inducible nitric oxide synthase (iNOS) using total RNA extracted from freshly isolated gland fragments. Lanes 2-4 represent the proliferative phase and lanes 5-7 the secretory phase. Lane 1 is a 123 bp ladder and lane 8 is a negative control from which cDNA was omitted. Five out of six specimens produced an intense band of the appropriate size (486 bp) for the eNOS amplimer. One proliferative phase specimen (lane 4) produced a much fainter band of the same size. RT-PCR with iNOS primers produced a major band of the predicted size (375 bp) in five out of six specimens. This product had 99% sequence homology with the published human iNOS sequence. Products of higher molecular weight were also observed in three secretory phase specimens although their identity is unknown.
Northern blotting might be due to the different sensitivities of Thus, the endometrium is thought to heal not by clot these two techniques.
organization and subsequent scarring, but by vasoconstriction Although not found in stromal cells throughout the normal followed by the growth of new blood vessels. cycle, iNOS-like immunoreactivity was present in stromal Endometrially-derived NO could also contribute to the cells which had undergone decidualization following either local control of myometrial contractility (Izumi et al., 1993 ; the administration of synthetic progestagen in vivo, or the Buhimschi et al., 1995) . Much attention has focused on establishment of pregnancy. This in-vivo study does not the part that NO might play in maintaining myometrial discriminate between a direct effect of progesterone on iNOS quiescence during pregnancy, suggesting NO administration expression or a secondary effect of local paracrine mediators as a therapeutic approach for the treatment of pre-term labour that are induced by progesterone. In this study we have (see Norman and Cameron, 1996 for review). Nitric oxide obtained no evidence for effects of oestrogen on eNOS and also appears to relax the non-pregnant myometrium, an action iNOS expression in human endometrium. Similarly in the which could be exploited for the medical treatment of primary sheep uterus exogenous oestrogen had no effect on NOS in dysmenorrhoea (Pittrof et al., 1996) . the endometrium although it increased Ca 2ϩ -dependent NOS Nitric oxide can be released from vascular endothelium by in the myometrium (Figueroa and Massmann, 1995) . a range of stimuli, including endothelin (ET) binding to Identification of eNOS and iNOS in human endometrium the ET B receptor (Takayanagi et al., 1991) . Endothelin-like suggests that NO may be involved in the local control of immunoreactivity is found on vascular endothelium and uterine function. Moreover, localization of NOS to vascular glandular epithelium in human endometrium (Cameron et al. , and non-vascular tissues would not preclude a predominant 1992; Salamonsen et al., 1992) . Furthermore, ET B receptors action on the uterine vascular bed. For example, the renal are predominantly localized to the same cell type as NOStubular epithelial cells of the macula densa release NO like immunoreactivity in the endometrium, namely glandular which dilates the neighbouring afferent artery to increase the epithelium (Collett et al., 1996) . The precise relationships glomerular filtration rate (Wilcox et al., 1992) . Nitric oxide between NO, ETs and other locally-produced mediators of might participate in both the initiation and control of menstrual endometrial function remain to be elucidated. bleeding. According to Markee (1940) , the onset of menstruation is preceded by endometrial regression, vasoconstriction and then vasodilatation. Nitric oxide could histological assessment of endometrial biopsies, the consultant gynaecologists at the West Glasgow Hospitals University NHS Trust staining and objectively-measured menstrual blood loss was deposition of platelet-fibrin plugs (Christiaens et al., 1980) .
